
RFIL · Nasdaq
Consensus is Buy, backed by one analyst, with a stated mean target of $17; formal low and high targets are unavailable. The published target evidence is much wider than that single-consensus count suggests: B. Riley’s target is $10.25, another source cites $11.25, and the consensus mean is $17. The unnamed analyst behind the $17 estimate is the most bullish identifiable view, while B. Riley is least bullish among named firms. Available evidence points to upward target revisions, including B. Riley’s move from $9.25 to $10.25, but does not date those changes to the past week. The substantive disagreement is between a bullish earnings and valuation case and a Neutral view near the current price.